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plete radiologic response after curative resection or ablation,
subsequently treated with DAAs. DAA-untreated patients from
ITA.LI.CA. cohort (n = 328) served as controls. After propensity-score
matching, outcomes of 102 DAA-treated (DAA group) and 102 DAA-
untreated patients (No DAA group) were compared.
Results: In DAA group, 7/102 patients (6.9%) died, HCC
recurred in 28/102 patients (27.5%) and hepatic decompensa-
tion occurred in 6/102 patients (5.9%), after a mean follow-up
of 21.4 months. OS was significantly higher in DAA group com-
pared with No DAA group (hazard ratio [HR] = 0.39; 95% confidence
Interval [CI] = 0.17âŁ“0.91, p = 0.03). HCC recurrence was not sig-
nificantly different between DAA and No DAA groups (HR = 0.70;
95%CI = 0.44âŁ“1.13, p = 0.15). A significant reduction in the rate
of hepatic decompensation was observed in DAA group com-
pared with No DAA group (HR = 0.32; 95%CI = 0.13-0.84, p = 0.02).
In DAA group, sustained virologic response was a significant pre-
dictor of overall survival (HR 0.02, 95%CI 0.00âŁ“0.19, p < 0.001),
HCC recurrence (HR 0.25, 95%CI 0.11âŁ“0.57, p < 0.001) and hepatic
decompensation (HR 0.12, 95%CI 0.02-0.38, p = 0.02).
Conclusions: In patients with HCV-related cirrhosis and previ-
ous successful treatment of early HCC, DAAs significantly improved
OS compared with No DAA treatment.
https://doi.org/10.1016/j.dld.2018.11.104
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Introduction and aim: Activating somatic mutations in the
promoter region of telomerase reverse transcriptase (TERT) gene
are common events in hepatocellular carcinoma (HCC). Sanger
nucleotide sequencing of end-point PCR amplified products is fre-
quently used for mutation detection despite the limited sensitivity.
Droplet digital PCR (ddPCR) is a highly sensitive technique and
provides the absolute quantification of mutant alleles. We have
developed and validated a probe-based ddPCR assay for detection
of the TERT promoter mutation -124 G>A in a series of viral hepatitis
related HCC.
Materials and methods: One-hundred-ten HCC cases, previ-
ously analysed for TERT promoter mutations by PCR and Sanger
sequencing, were tested by ddPCR using a probe-based assay
detecting the common hot spot mutation -124 G > A within the
TERT promoter region.
Results: Overall, 75 HCC samples out of 110 (68.2%) were found
mutated at position -124 in the TERT promoter region by ddPCR.
Eighty-three percent concordance was observed between ddPCR
and Sanger sequencing. The use of ddPCR allowed to identify 18
previously unrecognized mutated HCC. Notably, the mutated cases
identified only by the use of ddPCR showed a mean mutant allele
frequency (MAF) of 13.4%. Overall, the MAF observed in our analysis
ranged from 0.10% to 73%. The majority of mutated cases (n = 51)
showed a MAF lower than 45% suggesting a heterogeneous com-
position of the tumour tissue. Fourteen TERT promoter mutated
cases showed a MAF ranging from 55% to 73%, suggestive of loss of
heterozygosity of TERT gene, which was associated with advanced
stage of HCC.
Conclusions: The detection of TERT promoter mutation -124
G>A by ddPCR showed a remarkable high prevalence (68.2%) in our
series of HCC confirming that such mutation represents a specific
signature of liver cancer and that such strategy may be used as
reliable biomarker for the early identification of neoplastic nodules
in cirrhosis.
https://doi.org/10.1016/j.dld.2018.11.105
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Introduction: HCC is the second cause of cancer-related death
worldwide. In the last years, the role of nuclear receptors in hepa-
tocarcinogenesis has received great attention. COUP-TF2 regulates
important biological processes and. studies indicate that is a pro-
oncogenic factor but its role in HCC is still controversial.
Aim of this study was to evaluate the role of COUP-TF2 in HCC.
Materials and methods: Results COUP-TF2, evaluated by
immunohistochemistry, is over-expressed in primary HCC sam-
ples and Kaplan–Meier and Cox regression analysis show that
it may be an independent prognostic factor of worst outcome.
Overexpression of COUP-TF2, through stable transfection with
pcR3.1/COUP-TF2, has no significant effects on cell proliferation.
The migration and the ability to colonize sites distant from the
growth front were evaluated by Time-Laps microscopy showing
that COUP-TF2 induces a pro-metastatic phenotype characterized
by an increased anoikis resistance and amoeboid migration. West-
ern blot and immunofluorescences show that proteins involved
in the organization of the cytoskeleton, cell-cell or cell-substrate,
were differently modulated in COUP-TF2 overexpressing vs con-
trol cells. After we studied the role of COUP-TF2 in an in vivo
models of mouse carcinogenesis (TgN(Alb1HBV)44Bri) realizing
a triple transgenic animal where the liver-specific Cre expres-
sion deletes COUP-TF2 in hepatocytes (Tg[HBV]CreKOCOUP-TF2).
COUP-TF2 deletion reduces tumour growth. Finally, for to evaluate
the role of COUP-TF2 in metastasis formation we used a xenograft
model where mice were inoculated with human smmc7721 hep-
atocarcinoma cells stable transfected with COUP-TF2 or silenced
by specific short hairpin. COUP-TF2 overexpression induces an
increase, number of lung metastasis whereas its deletion reduces
pulmonary metastasis compared to control animals.
Conclusion: In the light of our data, COUP-TF2 appears to play
a role in the metastatic progression of HCC. The evidence that
COUP-TF2 transcriptional activity could be potentially regulated
by ligands, indicates that this nuclear receptor is a promising ther-
apeutic target for HCC.
https://doi.org/10.1016/j.dld.2018.11.106
